Retinoblastoma , our experience

Bibliographic Details
Main Author: Coutinho, I
Publication Date: 2013
Other Authors: Santos, C, Ramalho, M, Cabral, J, Teixeira, S
Language: eng
Source: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
Download full: http://hdl.handle.net/10400.10/1325
Summary: Introduction: The retinoblastoma is the most common malignant ocular tumor of childhood with an incidence of 1: 15000 – 20000 births and it is due to a mutation on RB1 gene, a tumoral supressor gene. The average age of diagnosis is 12 months in bilateral and 24 months in unilateral cases. Late diagnosis usually means lost of eye function or even death, that’s why the early screening in every child is so critical. Goals: Review and approach the diagnosis and current treatment of retinoblastoma. Describe the experience in treatment and follow-up of the children in our hospital, a Portuguese not central hospital near Lisbon. Methods: Review of the literature. Retrospective evaluation of the patients treated in the last 8 years in our hospital, together with the Oncology Portuguese Institute of Lisbon, using local (lasertherapy, cryotherapy and enucleation) and systemic (chemotherapy) therapy. Results: 7 patients were treated with unilateral retinoblastoma and 4 with bilateral disease. They were send to us by the assistant physician (pediatrician, ophthalmologist and general practice physician) because a positive familiar history, emerge of leucocory or strabismus. The average age was 21 months and the most frequent group was D according international classification system for intraocular retinoblastoma In the 8 eyes where conservative treatment was possible, after chemoreduction they were submitted to LASER Árgon or cryotherapy, according to the tumor location. In Five of these eyes there were also treated with transpupilar thermotherapy (TTP), brachytherapy, intra-vitreous or intra -arterial chemotherapy, in Laussane, at the Jules-Gonin Ophthalmic Hospital. 4 eyes were first enucleated and another 3 were secondary enucleated. The authors exhibit images taken before, during and after treatment Conclusion: Leucocory and strabism are the main forms of presentation of retinoblastoma. The treatment depends of the size of the tumor, laterality, eyesight potential and age of the child. The main therapeutic approaches are systemic chemotherapy with local therapies like cryotherapy, lasertherapy ,TTP, intra-arterial and intra-vitreous chemotherapy, brachytherapy and enucleation. Earlier diagnosis and treatment increase the number of patients that remain free of disease and preserve the vision. The treatment of these patients require a multidisciplinar team and frequent re-evaluations to detect recurrence, diagnosis of other tumors, such as sarcomas, that have increased incidence in survivors, as the genetic counseling to the patient and parents.
id RCAP_ccd95ce78620b2454028c2cbae6b10d8
oai_identifier_str oai:repositorio.hff.min-saude.pt:10400.10/1325
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling Retinoblastoma , our experienceRetinoblastomaRetinal neoplasmsNeoplasias da retinaIntroduction: The retinoblastoma is the most common malignant ocular tumor of childhood with an incidence of 1: 15000 – 20000 births and it is due to a mutation on RB1 gene, a tumoral supressor gene. The average age of diagnosis is 12 months in bilateral and 24 months in unilateral cases. Late diagnosis usually means lost of eye function or even death, that’s why the early screening in every child is so critical. Goals: Review and approach the diagnosis and current treatment of retinoblastoma. Describe the experience in treatment and follow-up of the children in our hospital, a Portuguese not central hospital near Lisbon. Methods: Review of the literature. Retrospective evaluation of the patients treated in the last 8 years in our hospital, together with the Oncology Portuguese Institute of Lisbon, using local (lasertherapy, cryotherapy and enucleation) and systemic (chemotherapy) therapy. Results: 7 patients were treated with unilateral retinoblastoma and 4 with bilateral disease. They were send to us by the assistant physician (pediatrician, ophthalmologist and general practice physician) because a positive familiar history, emerge of leucocory or strabismus. The average age was 21 months and the most frequent group was D according international classification system for intraocular retinoblastoma In the 8 eyes where conservative treatment was possible, after chemoreduction they were submitted to LASER Árgon or cryotherapy, according to the tumor location. In Five of these eyes there were also treated with transpupilar thermotherapy (TTP), brachytherapy, intra-vitreous or intra -arterial chemotherapy, in Laussane, at the Jules-Gonin Ophthalmic Hospital. 4 eyes were first enucleated and another 3 were secondary enucleated. The authors exhibit images taken before, during and after treatment Conclusion: Leucocory and strabism are the main forms of presentation of retinoblastoma. The treatment depends of the size of the tumor, laterality, eyesight potential and age of the child. The main therapeutic approaches are systemic chemotherapy with local therapies like cryotherapy, lasertherapy ,TTP, intra-arterial and intra-vitreous chemotherapy, brachytherapy and enucleation. Earlier diagnosis and treatment increase the number of patients that remain free of disease and preserve the vision. The treatment of these patients require a multidisciplinar team and frequent re-evaluations to detect recurrence, diagnosis of other tumors, such as sarcomas, that have increased incidence in survivors, as the genetic counseling to the patient and parents.International Society for Genetic Eye Diseases and RetinoblastomaUnidade Local de Saúde Amadora / SintraCoutinho, ISantos, CRamalho, MCabral, JTeixeira, S2015-01-09T16:25:36Z20132013-01-01T00:00:00Zconference objectinfo:eu-repo/semantics/publishedVersionapplication/pdfhttp://hdl.handle.net/10400.10/1325enginfo:eu-repo/semantics/openAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2025-03-10T15:03:07Zoai:repositorio.hff.min-saude.pt:10400.10/1325Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-29T01:16:22.361446Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv Retinoblastoma , our experience
title Retinoblastoma , our experience
spellingShingle Retinoblastoma , our experience
Coutinho, I
Retinoblastoma
Retinal neoplasms
Neoplasias da retina
title_short Retinoblastoma , our experience
title_full Retinoblastoma , our experience
title_fullStr Retinoblastoma , our experience
title_full_unstemmed Retinoblastoma , our experience
title_sort Retinoblastoma , our experience
author Coutinho, I
author_facet Coutinho, I
Santos, C
Ramalho, M
Cabral, J
Teixeira, S
author_role author
author2 Santos, C
Ramalho, M
Cabral, J
Teixeira, S
author2_role author
author
author
author
dc.contributor.none.fl_str_mv Unidade Local de Saúde Amadora / Sintra
dc.contributor.author.fl_str_mv Coutinho, I
Santos, C
Ramalho, M
Cabral, J
Teixeira, S
dc.subject.por.fl_str_mv Retinoblastoma
Retinal neoplasms
Neoplasias da retina
topic Retinoblastoma
Retinal neoplasms
Neoplasias da retina
description Introduction: The retinoblastoma is the most common malignant ocular tumor of childhood with an incidence of 1: 15000 – 20000 births and it is due to a mutation on RB1 gene, a tumoral supressor gene. The average age of diagnosis is 12 months in bilateral and 24 months in unilateral cases. Late diagnosis usually means lost of eye function or even death, that’s why the early screening in every child is so critical. Goals: Review and approach the diagnosis and current treatment of retinoblastoma. Describe the experience in treatment and follow-up of the children in our hospital, a Portuguese not central hospital near Lisbon. Methods: Review of the literature. Retrospective evaluation of the patients treated in the last 8 years in our hospital, together with the Oncology Portuguese Institute of Lisbon, using local (lasertherapy, cryotherapy and enucleation) and systemic (chemotherapy) therapy. Results: 7 patients were treated with unilateral retinoblastoma and 4 with bilateral disease. They were send to us by the assistant physician (pediatrician, ophthalmologist and general practice physician) because a positive familiar history, emerge of leucocory or strabismus. The average age was 21 months and the most frequent group was D according international classification system for intraocular retinoblastoma In the 8 eyes where conservative treatment was possible, after chemoreduction they were submitted to LASER Árgon or cryotherapy, according to the tumor location. In Five of these eyes there were also treated with transpupilar thermotherapy (TTP), brachytherapy, intra-vitreous or intra -arterial chemotherapy, in Laussane, at the Jules-Gonin Ophthalmic Hospital. 4 eyes were first enucleated and another 3 were secondary enucleated. The authors exhibit images taken before, during and after treatment Conclusion: Leucocory and strabism are the main forms of presentation of retinoblastoma. The treatment depends of the size of the tumor, laterality, eyesight potential and age of the child. The main therapeutic approaches are systemic chemotherapy with local therapies like cryotherapy, lasertherapy ,TTP, intra-arterial and intra-vitreous chemotherapy, brachytherapy and enucleation. Earlier diagnosis and treatment increase the number of patients that remain free of disease and preserve the vision. The treatment of these patients require a multidisciplinar team and frequent re-evaluations to detect recurrence, diagnosis of other tumors, such as sarcomas, that have increased incidence in survivors, as the genetic counseling to the patient and parents.
publishDate 2013
dc.date.none.fl_str_mv 2013
2013-01-01T00:00:00Z
2015-01-09T16:25:36Z
dc.type.driver.fl_str_mv conference object
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.10/1325
url http://hdl.handle.net/10400.10/1325
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv International Society for Genetic Eye Diseases and Retinoblastoma
publisher.none.fl_str_mv International Society for Genetic Eye Diseases and Retinoblastoma
dc.source.none.fl_str_mv reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833600900664393728